FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153200967> ?p ?o ?g. }

• W2153200967 endingPage "26" @default.
• W2153200967 startingPage "22" @default.
• W2153200967 abstract "Introduction: Antiangiogenic agents are often administered for treatment of Branch Retinal Vein Occlusion (BRVO). Among them, Bevacizumab has noticeable antiangiogenic and antiedemigenic properties and possesses great capacity to penetrate the retinal tissue, particularly in pathological circumstances characterized by altered external or internal blood-retinal barrier.Bevacizumab has an optimal bio-efficacy based on inhibition of the activity of Vascular Endothelial Growth Factor (VEGF). Nonetheless, despite its efficacy, here we describe the adverse effects associated with intraocular injection of bevacizumab in a patient affected by retinal vein occlusion. Case presentation: We present a case report of an 11-year old Caucasian malesubject affected by BRVO in his left eye. The patient underwent an intra-vitreal (i.v.) injection of bevacizumab 100 (1.25 mg/0.05ml). After that, the patient was monitored over time through a series of analyses including Ocular Coherence Tomography, Fluorangiography, Bulbar Ultrasound, Angio MRI BCVA scores and Intra Ocular Pressure. Results: Immediately after the i.v. injection, the patient experienced a strong and relentless pain radiating from the left ocular orbit, caused by a serious and unexpected malignant glaucoma and phthisis bulbi. Furthermore, the patient did not show any sign of improvement in visual function in the follow-up and at last required an ophthalmic prosthesisas a result of a sub-atrophic and hypotonic eyeball. Conclusion: This case report suggests that i.v. injections of anti-VEGFs should be considered with caution when treating central and branch vein occlusion, and are not free of complications in certain clinical cases." @default.
• W2153200967 created "2016-06-24" @default.
• W2153200967 creator A5006283433 @default.
• W2153200967 creator A5018355297 @default.
• W2153200967 creator A5025471773 @default.
• W2153200967 creator A5052976432 @default.
• W2153200967 creator A5064895227 @default.
• W2153200967 creator A5074310950 @default.
• W2153200967 creator A5077903669 @default.
• W2153200967 creator A5080667573 @default.
• W2153200967 date "2015-01-23" @default.
• W2153200967 modified "2023-09-26" @default.
• W2153200967 title "Adverse Events Associated with Intraocular Injection of Anti-VEGF(bevacizumab) in Retinal Vein Occlusion: A Case Report" @default.
• W2153200967 cites W1594638966 @default.
• W2153200967 cites W161240884 @default.
• W2153200967 cites W1976993504 @default.
• W2153200967 cites W1978037771 @default.
• W2153200967 cites W1989729487 @default.
• W2153200967 cites W2002861350 @default.
• W2153200967 cites W2013425190 @default.
• W2153200967 cites W2023874692 @default.
• W2153200967 cites W2026986060 @default.
• W2153200967 cites W2030362969 @default.
• W2153200967 cites W2032740636 @default.
• W2153200967 cites W2033046224 @default.
• W2153200967 cites W2033680298 @default.
• W2153200967 cites W2053662423 @default.
• W2153200967 cites W2058775052 @default.
• W2153200967 cites W2059317138 @default.
• W2153200967 cites W2069220590 @default.
• W2153200967 cites W2070631516 @default.
• W2153200967 cites W2084610216 @default.
• W2153200967 cites W2085947188 @default.
• W2153200967 cites W2104689293 @default.
• W2153200967 cites W2126124189 @default.
• W2153200967 cites W2131912060 @default.
• W2153200967 cites W2153035067 @default.
• W2153200967 cites W2399606387 @default.
• W2153200967 cites W2413880953 @default.
• W2153200967 cites W321665048 @default.
• W2153200967 doi "https://doi.org/10.12691/novn-1-1-5" @default.
• W2153200967 hasPublicationYear "2015" @default.
• W2153200967 type Work @default.
• W2153200967 sameAs 2153200967 @default.
• W2153200967 citedByCount "0" @default.
• W2153200967 crossrefType "journal-article" @default.
• W2153200967 hasAuthorship W2153200967A5006283433 @default.
• W2153200967 hasAuthorship W2153200967A5018355297 @default.
• W2153200967 hasAuthorship W2153200967A5025471773 @default.
• W2153200967 hasAuthorship W2153200967A5052976432 @default.
• W2153200967 hasAuthorship W2153200967A5064895227 @default.
• W2153200967 hasAuthorship W2153200967A5074310950 @default.
• W2153200967 hasAuthorship W2153200967A5077903669 @default.
• W2153200967 hasAuthorship W2153200967A5080667573 @default.
• W2153200967 hasConcept C118487528 @default.
• W2153200967 hasConcept C126322002 @default.
• W2153200967 hasConcept C141071460 @default.
• W2153200967 hasConcept C197934379 @default.
• W2153200967 hasConcept C2776268601 @default.
• W2153200967 hasConcept C2776694085 @default.
• W2153200967 hasConcept C2777802072 @default.
• W2153200967 hasConcept C2778402387 @default.
• W2153200967 hasConcept C2778527774 @default.
• W2153200967 hasConcept C2778844676 @default.
• W2153200967 hasConcept C2780261187 @default.
• W2153200967 hasConcept C2780347916 @default.
• W2153200967 hasConcept C2780463659 @default.
• W2153200967 hasConcept C2780827179 @default.
• W2153200967 hasConcept C2781092963 @default.
• W2153200967 hasConcept C2908732032 @default.
• W2153200967 hasConcept C71924100 @default.
• W2153200967 hasConceptScore W2153200967C118487528 @default.
• W2153200967 hasConceptScore W2153200967C126322002 @default.
• W2153200967 hasConceptScore W2153200967C141071460 @default.
• W2153200967 hasConceptScore W2153200967C197934379 @default.
• W2153200967 hasConceptScore W2153200967C2776268601 @default.
• W2153200967 hasConceptScore W2153200967C2776694085 @default.
• W2153200967 hasConceptScore W2153200967C2777802072 @default.
• W2153200967 hasConceptScore W2153200967C2778402387 @default.
• W2153200967 hasConceptScore W2153200967C2778527774 @default.
• W2153200967 hasConceptScore W2153200967C2778844676 @default.
• W2153200967 hasConceptScore W2153200967C2780261187 @default.
• W2153200967 hasConceptScore W2153200967C2780347916 @default.
• W2153200967 hasConceptScore W2153200967C2780463659 @default.
• W2153200967 hasConceptScore W2153200967C2780827179 @default.
• W2153200967 hasConceptScore W2153200967C2781092963 @default.
• W2153200967 hasConceptScore W2153200967C2908732032 @default.
• W2153200967 hasConceptScore W2153200967C71924100 @default.
• W2153200967 hasIssue "1" @default.
• W2153200967 hasLocation W21532009671 @default.
• W2153200967 hasOpenAccess W2153200967 @default.
• W2153200967 hasPrimaryLocation W21532009671 @default.
• W2153200967 hasRelatedWork W1542916056 @default.
• W2153200967 hasRelatedWork W1767674675 @default.
• W2153200967 hasRelatedWork W1965215960 @default.
• W2153200967 hasRelatedWork W1992886354 @default.
• W2153200967 hasRelatedWork W2002105731 @default.
• W2153200967 hasRelatedWork W2016212397 @default.

• next